Lyell Immunopharma (LYEL)
11.97
-1.08 (8.28%)
Upcoming Events
Latest Headlines
Lyell Immunopharma to present ronde-cel data at EHA 2026 congress
June 4, 2026 4:05 PM - StreetInsider
Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress
June 4, 2026 4:05 PM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Lyell Immunopharma (LYEL)
June 3, 2026 6:55 AM - StreetInsider
Lyell Immunopharma Announces Participation in Goldman Sachs 47th Annual Global Healthcare Conference 2026
June 1, 2026 8:00 AM - StreetInsider
Form SCHEDULE 13G/A Lyell Immunopharma, Inc. Filed by: ARCH Venture Fund IX, L.P.
May 15, 2026 4:08 PM - SEC Filing
Lyell Immunopharma Announces Participation in May Investor Conferences
May 12, 2026 8:00 AM - Globe NewsWire
Form SCHEDULE 13G/A Lyell Immunopharma, Inc. Filed by: MWG Caph Ltd
May 11, 2026 11:12 AM - SEC Filing
Form SCHEDULE 13G/A Lyell Immunopharma, Inc. Filed by: Explore Investments LLC/DE
May 8, 2026 4:24 PM - SEC Filing
Form 10-Q Lyell Immunopharma, Inc. For: Mar 31
May 6, 2026 4:15 PM - SEC Filing
Form 8-K Lyell Immunopharma, Inc. For: May 06
May 6, 2026 4:12 PM - SEC Filing
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026
May 6, 2026 4:05 PM - StreetInsider
BofA Securities Reiterates Underperform Rating on Lyell Immunopharma (LYEL), PT $12, 'we continue to view the story cautiously'
May 1, 2026 5:29 AM - StreetInsider
Baird Starts Lyell Immunopharma (LYEL) at Outperform
April 30, 2026 4:11 PM - StreetInsider
Form ARS Lyell Immunopharma, Inc. For: Dec 31
April 24, 2026 4:09 PM - SEC Filing
Form DEFA14A Lyell Immunopharma, Inc.
April 24, 2026 4:08 PM - SEC Filing
Form DEF 14A Lyell Immunopharma, Inc. For: Jun 10
April 24, 2026 4:06 PM - SEC Filing
Form SCHEDULE 13G Lyell Immunopharma, Inc. Filed by: Euler Fund, L.P.
April 21, 2026 9:00 AM - SEC Filing
Form EFFECT Lyell Immunopharma, Inc.
April 15, 2026 6:23 AM - SEC Filing
Needham Starts Lyell Immunopharma (LYEL) at Buy
April 10, 2026 5:54 AM - StreetInsider
Lyell Immunopharma Announces Participation in 25th Annual Needham Virtual Healthcare Conference
April 7, 2026 12:36 PM - Globe NewsWire
Lyell Immunopharma Announces Participation in 25th Annual Needham Virtual Healthcare Conference
April 7, 2026 8:14 AM - StreetInsider
Form S-3 Lyell Immunopharma, Inc.
April 3, 2026 4:23 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Lyell Immunopharma (LYEL)
March 23, 2026 6:48 AM - StreetInsider
Form 4 Lyell Immunopharma, Inc. For: Mar 09 Filed by: Shah Smital
March 16, 2026 7:26 PM - SEC Filing
Form 3 Lyell Immunopharma, Inc. For: Mar 09 Filed by: Shah Smital
March 16, 2026 7:25 PM - SEC Filing
Citizens Reiterates Market Outperform Rating on Lyell Immunopharma (LYEL)
March 16, 2026 5:02 AM - StreetInsider
Form S-8 Lyell Immunopharma, Inc.
March 12, 2026 4:51 PM - SEC Filing
Form 10-K Lyell Immunopharma, Inc. For: Dec 31
March 12, 2026 4:19 PM - SEC Filing
Form 8-K Lyell Immunopharma, Inc. For: Mar 12
March 12, 2026 4:14 PM - SEC Filing
Lyell Immunopharma Reports Q4 and Full Year 2025 Business and Financial Results
March 12, 2026 4:05 PM - StreetInsider
Full Article List
